Head-to-head · Cost-Efficiency Index
Ways2Well vs Robinhood Telehealth
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Ways2Well
Patients wanting a broad, opaque-pricing concierge biomarker/longevity membership rather than a dedicated, transparently-priced GLP-1 program.
Visit Ways2WellRobinhood Telehealth
Shoppers who want GLP-1 care bundled with a long peptide menu and are willing to get their price in the eligibility check.
Visit Robinhood TelehealthThe verdict
Ways2Well and Robinhood Telehealth tie on the Cost-Efficiency Index at 41/100, so neither wins outright on the numbers, so choose on fit. Ways2Well: Patients wanting a broad, opaque-pricing concierge biomarker/longevity membership rather than a dedicated, transparently-priced GLP-1 program. Robinhood Telehealth: Shoppers who want GLP-1 care bundled with a long peptide menu and are willing to get their price in the eligibility check.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Ways2Well.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Ways2Well | Robinhood Telehealth |
|---|---|---|
| Cost-Efficiency Index | 41/100 | 41/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #594 | #598 |
Ways2Well
41/100Where the value is
- Backed by a known founder (Brigham Buhler) with an established functional-medicine brand
- Offers a broader diagnostic workup (100+ biomarkers, biannual panels) than typical single-purpose GLP-1 telehealth sites
- Confirms semaglutide/tirzepatide can be included in a custom protocol via a dedicated /semaglutide page
The tradeoffs
- No published GLP-1 pricing on its site -- fully gated behind consultation/membership
- No published membership price either
Robinhood Telehealth
41/100Where the value is
- Offers compounded semaglutide, tirzepatide and a low-dose GLP-1 microdose program, plus peptides like sermorelin, BPC-157 and NAD+
- Says a licensed U.S. physician approves every protocol and that you aren't charged if you're not approved
- One bundled monthly price covers the provider fee, the pharmacy fee and the medication, according to its terms
The tradeoffs
- No price for any specific medication is published; the only figure is a 'from $149/mo' banner covering GLP-1 and peptide programs
- Doesn't list the states it serves or name its pharmacies or medical group
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.